These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14723111)

  • 1. Medications for dry eye syndrome: a drug-therapy review.
    Perry HD; Donnenfeld ED
    Manag Care; 2003 Dec; 12(12 Suppl):26-32. PubMed ID: 14723111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation: a unifying theory for the origin of dry eye syndrome.
    Wilson SE
    Manag Care; 2003 Dec; 12(12 Suppl):14-9. PubMed ID: 14723109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the treatment of chronic dry eye disease.
    Sheppard JD
    Manag Care; 2003 Dec; 12(12 Suppl):20-5. PubMed ID: 14723110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe, unilateral, unresponsive keratoconjunctivitis sicca in 16 juvenile Yorkshire Terriers.
    Herrera HD; Weichsler N; Gómez JR; de Jalón JA
    Vet Ophthalmol; 2007; 10(5):285-8. PubMed ID: 17760706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry eye moves beyond palliative therapy.
    Sheppard JD
    Manag Care; 2003 Dec; 12(12 Suppl):6-8. PubMed ID: 14723107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiinflammatory therapy for dry eye.
    Pflugfelder SC
    Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic cyclosporine (Restasis) for dry eye disease.
    Med Lett Drugs Ther; 2003 May; 45(1157):42-3. PubMed ID: 12766701
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys.
    Trattler W; Katsev D; Kerney D
    Clin Ther; 2006 Nov; 28(11):1848-56. PubMed ID: 17213005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of keratoconjunctivitis sicca in the dog.
    Williams DL
    Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):251-68, vi. PubMed ID: 18299006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear film: new concepts and implications for the management of the dry eye.
    Lemp MA
    Trans New Orleans Acad Ophthalmol; 1987; 35():53-64. PubMed ID: 3441945
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding dry eye disease: a managed care perspective.
    Fiscella RG
    Am J Manag Care; 2011 Dec; 17 Suppl 16():S432-9. PubMed ID: 22435675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A; English RV; Nadelstein B
    Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dry eye disease.
    Lemp MA
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S88-101. PubMed ID: 18452372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of hyaluronic acid eyedrops in the treatment of dry eye. Cytologic study using an optical microscope and computerized microscope].
    Orsoni JG; Chiari M; Guazzi A; de Carli M; Guidolin D
    Ophtalmologie; 1988 Oct; 2(4):355-7. PubMed ID: 3247208
    [No Abstract]   [Full Text] [Related]  

  • 19. Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva.
    Chen W; Zhao K; Li X; Yoshitomi T
    Cornea; 2007 Oct; 26(9):1101-6. PubMed ID: 17893543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca.
    Stonecipher K; Perry HD; Gross RH; Kerney DL
    Curr Med Res Opin; 2005 Jul; 21(7):1057-63. PubMed ID: 16004673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.